top of page

ABOUT US

The Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) was established in 1995 to improve understanding of the basic science and the clinical management of inherited gastrointestinal cancers. 

Vision Statement​

​

The vision of the CGA-IGC is to eliminate morbidity and early mortality of hereditary gastrointestinal cancers.

Mission Statement​

​

The mission of the CGA-IGC is to advance science and clinical care of inherited gastrointestinal cancers through research and education as the leading authority in the Americas. Through this mission, the CGA-IGC offers the following:

  • Education regarding the clinical management and molecular genetics of inherited gastrointestinal cancer to physicians, allied healthcare professionals, patients, and their families.

  • Access to collaborative trials and studies.

  • Resources for developing new hereditary registries and supporting their registries

  • A forum for exchange of ideas.

  • Multidisciplinary expertise in clinical care, healthcare policy, and research related to hereditary gastrointestinal cancer.

CGA-IGC Commitment to Justice, Equity, Diversity, and Inclusion

 

The Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) promotes diversity and inclusiveness throughout the organization including in its membership, governance, and education programming.  The CGA-IGC also recognizes the importance of advancing health equity in patient care in achieving our core mission as an organization.

 

The CGA-IGC is committed to:

  • Fostering an environment that is inclusive of all groups including, but not limited to, sex, race, ethnicity, gender identity, sexual orientation, religious beliefs, varying physical and mental abilities, professional specialty, and level of training.

  • Increasing diversity within the organization that mirrors the rich and heterogeneous skills and professions of the hereditary gastrointestinal cancer medical community.

  • Reducing disparities in health and healthcare and expanding research opportunities for patients and families at risk for gastrointestinal cancers.

The CGA-IGC's clinical, educational and research focus is hereditary gastrointestinal cancer syndromes, including but not limited to:​

  • Lynch Syndrome

  • Familial Adenomatous Polyposis (FAP)

  • MUTYH Associated Polyposis (MAP)

  • Hereditary Diffuse Gastric Cancer Syndrome

  • Gastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS)

  • Familial Pancreatic Cancer

  • Peutz-Jeghers Syndrome

  • Juvenile Polyposis Syndrome

  • PTEN Hamartoma Syndrome

  • Colon Polyposis of Unknown Etiology (CPUE)

  • Hereditary Mixed Polyposis Syndrome

  • Serrated Polyposis Syndrome

  • Polymerase Proofreading-Associated Polyposis (PPAP)

  • Moderate Penetrance Syndromes (including, but not limited to individuals with pathogenic variants in CHEK2, ATM, APC I1307K etc.)  

bottom of page